Cargando…
The Intestinal Redox System and Its Significance in Chemotherapy-Induced Intestinal Mucositis
Chemotherapy-induced intestinal mucositis (CIM) is a significant dose-limiting adverse reaction brought on by the cancer treatment. Multiple studies reported that reactive oxygen species (ROS) is rapidly produced during the initial stages of chemotherapy, when the drugs elicit direct damage to intes...
Autores principales: | Yu, Qing-Qing, Zhang, Heng, Guo, Yujin, Han, Baoqin, Jiang, Pei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110227/ https://www.ncbi.nlm.nih.gov/pubmed/35585883 http://dx.doi.org/10.1155/2022/7255497 |
Ejemplares similares
-
Systematic evaluation of irinotecan-induced intestinal mucositis based on metabolomics analysis
por: Yu, Qing-Qing, et al.
Publicado: (2022) -
Rhubarb extract partially improves mucosal integrity in chemotherapy-induced intestinal mucositis
por: Bajic, Juliana E, et al.
Publicado: (2016) -
SPAK Deficiency Attenuates Chemotherapy-Induced Intestinal Mucositis
por: Huang, Tien-Yu, et al.
Publicado: (2021) -
The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis
por: van Vliet, Michel J., et al.
Publicado: (2010) -
2’-Fucosyllactose Ameliorates Chemotherapy-Induced Intestinal Mucositis by Protecting Intestinal Epithelial Cells Against Apoptosis
por: Zhao, Gang, et al.
Publicado: (2021)